Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT05427812 · TERMINATED

Trial details

NCT number: NCT05427812
Sponsor: Ichnos Sciences SA
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2022-09-27
Primary completion: 2024-11-19
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.